• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物分子抑制 Aβ 聚集。

Inhibiting the Aggregation of Aβ by Natural Product Molecules.

机构信息

School of Future Technology, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China.

Fuzhou Institute of Oceanography, College of Materials and Chemical Engineering, Minjiang University, Fuzhou, Fujian 350108, China.

出版信息

ChemMedChem. 2024 Sep 2;19(17):e202400223. doi: 10.1002/cmdc.202400223. Epub 2024 Jul 15.

DOI:10.1002/cmdc.202400223
PMID:38807345
Abstract

The abnormal aggregation of Aβ has been considered one of the primary causative factors for Alzheimer's disease. Diverse molecular entities have been developed to mitigate the formation of toxic Aβ aggregates within the brain by inhibiting Aβ aggregation. Recognizing that many FDA-approved drugs are derived from natural products, we present a summary of recent discoveries involving natural product molecules with inhibitory effects on Aβ aggregation. By consolidating these findings, our review offers researchers a concise overview of the latest advancements in natural product-based interventions for Alzheimer's disease.

摘要

异常聚集的 Aβ 已被认为是阿尔茨海默病的主要致病因素之一。已经开发出多种分子实体来通过抑制 Aβ 聚集来减轻大脑中有毒 Aβ 聚集物的形成。鉴于许多 FDA 批准的药物源自天然产物,我们总结了具有抑制 Aβ 聚集作用的天然产物分子的最新发现。通过整合这些发现,我们的综述为研究人员提供了一个关于基于天然产物干预阿尔茨海默病的最新进展的简明概述。

相似文献

1
Inhibiting the Aggregation of Aβ by Natural Product Molecules.天然产物分子抑制 Aβ 聚集。
ChemMedChem. 2024 Sep 2;19(17):e202400223. doi: 10.1002/cmdc.202400223. Epub 2024 Jul 15.
2
Recent Progress in the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-peptide Aggregation.阿尔茨海默病治疗药物研发的最新进展——特别是对淀粉样肽聚集的抑制作用。
Mini Rev Med Chem. 2021;21(8):969-990. doi: 10.2174/1389557520666201127104539.
3
Natural Products Targeting Amyloid Beta in Alzheimer's Disease.天然产物靶向阿尔茨海默病中的淀粉样β
Int J Mol Sci. 2021 Feb 26;22(5):2341. doi: 10.3390/ijms22052341.
4
Inhibition of amyloid-β aggregation in Alzheimer's disease.阿尔茨海默病中β-淀粉样蛋白聚集的抑制作用
Curr Pharm Des. 2014;20(8):1223-43. doi: 10.2174/13816128113199990068.
5
Secondary Metabolites from Plants Possessing Inhibitory Properties against Beta-Amyloid Aggregation as Revealed by Thioflavin-T Assay and Correlations with Investigations on Transgenic Mouse Models of Alzheimer's Disease.植物中的次级代谢产物具有抑制β-淀粉样蛋白聚集的特性,这是通过噻唑蓝(Thioflavin-T) assay 发现的,并与阿尔茨海默病转基因小鼠模型的研究相关联。
Biomolecules. 2020 Jun 6;10(6):870. doi: 10.3390/biom10060870.
6
β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.作用于β-淀粉样蛋白聚集和纤维形成的β-折叠干扰分子。
Bioorg Med Chem. 2015 Apr 15;23(8):1671-83. doi: 10.1016/j.bmc.2015.02.041. Epub 2015 Feb 28.
7
Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease.针对淀粉样β聚集的肽类抑制剂:阿尔茨海默病的潜在治疗策略。
Future Med Chem. 2021 Oct;13(20):1767-1794. doi: 10.4155/fmc-2021-0184. Epub 2021 Sep 9.
8
Synthesis and evaluation of catecholamine derivatives as amyloid-beta aggregation inhibitors.合成与评价儿茶酚胺衍生物作为淀粉样β聚集抑制剂。
Bioorg Med Chem Lett. 2024 Jul 15;107:129788. doi: 10.1016/j.bmcl.2024.129788. Epub 2024 May 11.
9
Exploring the potential of pyrazoline containing molecules as Aβ aggregation inhibitors in Alzheimer's disease.探讨含吡唑啉分子作为阿尔茨海默病中 Aβ 聚集抑制剂的潜力。
Drug Metab Pers Ther. 2020 Aug 10;35(3):dmpt-2019-0031. doi: 10.1515/dmpt-2019-0031.
10
Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease.合理设计的肽和肽模拟物作为淀粉样β蛋白(Aβ)聚集的抑制剂:阿尔茨海默病的潜在治疗方法
ACS Comb Sci. 2017 Feb 13;19(2):55-80. doi: 10.1021/acscombsci.6b00116. Epub 2017 Jan 18.